Skip to main content
PLOS Currents logoLink to PLOS Currents
. 2017 Jul 11;9:ecurrents.hd.976177e0cbf724437ea11745c9231a57. [Version 1] doi: 10.1371/currents.hd.976177e0cbf724437ea11745c9231a57

Correction: Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease

PLOS Currents
PMCID: PMC5510914  PMID: 28856062

Correction

There is an error in the second author’s name. The correct name is Elizabeth A. Wang. The correct citation is Chen JY, Wang EA, Galvan L, Huynh M, Joshi P, Cepeda C, Levine MS. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLOS Currents Huntington Disease. 2013 Feb 5 . Edition 1. doi: 10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202.

Reference

Chen JY, Wang E, Galvan L, Huynh M, Joshi P, Cepeda C, Levine MS. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLOS Currents Huntington Disease. 2013 Feb 5 . Edition 1. doi: 10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202.


Articles from PLoS Currents are provided here courtesy of PLOS

RESOURCES